Methoxy Polyethylene Glycol-Epoetin Beta
Nutritional Deficiency Disease
Taipei Veterans General Hospital, Taiwanprotein_peptidePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Nutritional Deficiency Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Intralipid Johane Allard | Phase 4 | BB |
Retrovir International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Phase 4 | BB |
Guanfacine Maimonides Medical Center | Phase 4 | BB |
Lamivudine International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Phase 4 | BB |
Thalidomide Chinese University of Hong Kong | Phase 4 | BB |
View all 31 →
Same molecule, other indications
Methoxy Polyethylene Glycol-Epoetin Beta is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →